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The molecular complexity of mammalian proteomes demands new methods for mapping the
organization of multiprotein complexes. Here, we combine mouse genetics and proteomics to
characterize synapse protein complexes and interaction networks. New tandem affinity purification
(TAP) tagswere fused to the carboxyl terminus of PSD-95 using gene targeting inmice. Homozygous
mice showed no detectable abnormalities in PSD-95 expression, subcellular localization or synaptic
electrophysiological function. Analysis of multiprotein complexes purified under native conditions
by mass spectrometry defined known and new interactors: 118 proteins comprising crucial
functional components of synapses, including glutamate receptors, Kþ channels, scaffolding and
signaling proteins, were recovered. Network clustering of protein interactions generated five
connected clusters, with two clusters containing all the major ionotropic glutamate receptors and
one cluster with voltage-dependent Kþ channels. Annotation of clusters with human disease
associations revealed that multiple disorders map to the network, with a significant correlation
of schizophrenia within the glutamate receptor clusters. This targeted TAP tagging strategy is
generally applicable to mammalian proteomics and systems biology approaches to disease.
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Introduction
Synapses are fundamental structural and functional units of
the nervous system responsible for information processing.
Their principal role is the transmission of electrical activity by
the release of neurotransmitter from the presynaptic terminal
onto postsynaptic receptors and ion channels. Postsynaptic
ionotropic receptors initiate the postsynaptic depolarization
that elicits action potential generation in the postsynaptic
neuron. The second major role is the detection and processing
of information contained in the patterns of electrical activity.
This is achieved by the coupling of neurotransmitter receptors
to second-messenger signaling pathways that modulate down-
stream effectors, ranging from modulation of ion channels
themselves to structural changes and gene expression.
In recent years, proteomic studies have revealed that
mammalian synapses comprise up to 2000 proteins in the
presynaptic and postsynaptic terminals (Husi et al, 2000;
Walikonis et al, 2000; Husi and Grant, 2001; Sheng and Kim,
2002; Peng et al, 2004; Takamori et al, 2006; Trinidad et al,
2008). To understand the macromolecular organization of
complexes and substructures, isolation of complexes by
antibody, peptide and ligand affinity methods was used to
recover smaller sets of proteins (Husi et al, 2000; Farr et al,
2004; Collins et al, 2006; Dosemeci et al, 2007; Klemmer et al,
2009; Paulo et al, 2009). These methods generally involve a
single purification step, which is limited by the specificity of
the affinity reagent and potentially recovers more contami-
nants than those with multiple steps. Furthermore, these
protocols are not generally suitable for recovery of native
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complexes in solution, which could be used for enzymatic and
structural studies.
A potential solution to this major problem has been
achieved in yeast through genetic modification of the
endogenous protein by fusion with a Tandem Affinity
Purification (TAP) tag into the C- or N-terminus of the protein
of interest (Rigaut et al, 1999). This tagged protein can be
isolated (with its associated proteins) in a tandem procedure,
overcoming many of the inherent specificity and sensitivity
limitations of traditional fractionation methods, as well as
antibody, ligand and peptide affinity purification methods. In
mammalian tissues, where developmental and cell-type
control of regulation is more complex, the targeting of the
TAP tag into the endogenous gene provides advantages over
transgenic random integration or cDNA overexpression
systems (Knuesel et al, 2003; Bouwmeester et al, 2004;
Brajenovic et al, 2004; Drakas et al, 2005; Wang et al, 2005,
2006; Angrand et al, 2006; Burckstummer et al, 2006). For
those reasons we chose to explore TAP tagging in mammals
using gene targeting in mouse.
Our first aim was to test TAP tagging using a gene-targeting
approach in mice, with the specific objective of purifying
signaling complexes from the synapse. We generated knockin
mice in which TAP tags were inserted into the endogenous
locus of post synaptic density-95 (PSD-95), which is one of the
most abundant scaffold proteins at excitatory brain synapses
(Nourry et al, 2003; Peng et al, 2004). PSD-95 is localized to the
postsynaptic compartment in which it interacts with neuro-
transmitter receptors and ion channels to assemble signaling
complexes (Kornau et al, 1995; Hunt et al, 1996; Tu et al, 1999;
Husi et al, 2000; Nehring et al, 2000; Dosemeci et al, 2007)
controlling neuronal plasticity (Migaud et al, 1998; Carlisle
et al, 2008; Cuthbert et al, 2007) underlying learning and
memory (Migaud et al, 1998), pain (Garry et al, 2003) and drug
addiction (Yao et al, 2004). Our second aim was to integrate
TAP tag proteomic data with systems biology approaches to
analyze the organization and function of complexes.
We show the first example of gene-targeted TAP tagging in
mice and show that the tagging did not introduce amutation or
alter the expression or localization of the protein. Clear
advantages of two-step purification methods over the existing
single-step methods were found. Mass spectrometry analysis
of four replicates of the purification revealed that PSD-95-
associated complexes comprise the principal ionotropic
glutamate receptors and Kþ channels in addition to important
signaling proteins. Text mining and systematic annotation
together with clustering of proteins using protein interaction
data revealed the network substructure with a core subnet-
work involved in schizophrenia.
Results
A strategy for purification of in vivo multiprotein
complexes
We used a TAP tag consisting of a poly-histidine affinity
tag (HAT) and a triple FLAG tag (Terpe, 2003) in tandem,
separated by a unique TEV-protease cleavage site (Figure 1A).
This 5-kDa tag is considerably smaller than the tag first applied
in yeast (20 kDa) (Rigaut et al, 1999) and exploits the
specificity of both FLAG and HAT-tag binding. Targeting the
endogenous gene allows a thorough testing of the potential
mutant phenotype by breeding to homozygosity and compar-
ing with the existing mutant mice.
Generation of a TAP-tagged PSD-95 knockin
mouse line
We chose to test TAP tagging inmice, with a focus on PSD-95 as
a first model gene for the following reasons: (i) PSD-95 has
discrete expression in the postsynaptic compartment of
excitatory synapses of the brain, (ii) PSD-95 mutant mice are
well characterized and show robust phenotypes in electro-
physiological studies of synapses and behavior (Migaud et al,
1998; El-Husseini et al, 2000; Yao et al, 2004; Beique et al,
2006), and (iii) this protein has been extensively studied using
methods that identify binary interaction partners (Kim and
Sheng, 2004).
PSD-95 is a scaffold protein with three PDZ domains, an SH3
and a guanylate kinase domain that mediate protein interac-
tions (Figure 1A). As mouse PSD-95 is known to have multiple
isoforms generated bymultiple promoters and all forms utilize
a common C-terminus (Bence et al, 2005), the TAP tag was
inserted into the open reading frame in the 30-end before the
stop codon of exon 19, using Escherichia coli recombineering-
based methods (Zhou et al, 2004) (Figure 1B). The final
targeting vector, containing a 50-end homology arm of 6.3 kb
and a 30-end homology arm of 2.9 kb, was transfected into ES
cells and integration was detected using standard methods.
PCR of neomycin-resistant ES-cell DNA confirmed the ex-
pected 3388 bp band in 16 clones (targeting efficiency was
5.6%), and germline transmission of the TAP-tag insertionwas
established (Figure 1C). This line of mice is referred to herein
as PSD-95TAP.
Normal expression and synaptic localization
of TAP-tagged PSD-95
We first intercrossed PSD-95TAP heterozygous mice
(PSD-95TAP/þ ) and found no distortion of transmission
frequency in the offspring of PSD-95TAP/þ intercrosses (data
not shown). We next examined protein expression of TAP-
tagged PSD-95 to ensure that introduction of the tag into the
gene did not affect the expression and localization of the
tagged protein. The solubilization conditions used here have
been reported as the best conditions to mostly purify N-
methyl-D-aspartate (NMDA) receptors and PSD-95 from adult
mouse brain (Husi and Grant, 2001). The forebrain tissue was
solubilized from heterozygous (PSD-95TAP/þ ) mice and PSD-
95 was immunoprecipitated and immunoblotted using an anti-
PSD-95 antibody (Figure 1D). Two bands of similar intensity
were observed, where the upper band corresponded to the
TAP-tagged PSD-95 (confirmed by immunoprecipitation using
anti-FLAG antibody, right panel) and the lower band to the
endogenous PSD-95. Comparison of extracts (5, 10, 15 mg)
from wild-type (wt) and homozygous (PSD-95TAP/TAP) mice
showed similar amounts of PSD-95 on immunoblots compared
with an internal control immunoblot using anti-tubulin
antibody (Figure 1E).
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We next carried out immunohistochemistry with an anti-
PSD-95 antibody on sagittal brain sections to examine the
expression pattern of TAP-tagged PSD-95. As shown in
Figure 2A, the expression pattern of PSD-95 in PSD-95TAP/TAP
brain was the same as in the brains of wt animals, with
the highest expression in the CA1 area, dentate gyrus,
cortex, cerebellum and lower expression in striatum and
brainstem (Figure 2A). Therewas no detectable abnormality of
brain morphology in the PSD-95TAP/TAP mice. As shown in
Figure 2B, the expression of PSD-95 in the hippocampal
subfields was unaffected by the genetic manipulation and
particularly in the stratum radiatum, where the electrophysio-
logical experiments were carried out (described below), was
normal.
To examine the synaptic localization of TAP-tagged
PSD-95, we cultured embryonic hippocampal neurons from
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Figure 1 Generation of Tandem Affinity Purification (TAP)-tagged PSD-95 knockin mice. (A) Domain structure of TAP modified PSD-95. PSD-95 domains, including
three PDZ (PSD-95/discs large/zona occludens), a SH3 (Src homology 3), a GK (guanylate kinase) and C-terminal TAP-tag domain. Amino-acid sequence of the TAP
tag comprising a histidine affinity tag (HAT)-domain (bold), a TEV site (underlined) and a 3XFLAG domain (bold) separated by a spacer. (B) Scheme of the targeted
genomic PSD-95/Dlg4 locus. The Dlg4 allele was targeted with the TAP sequence inserted before the stop codon. Crossing the transgenic Cre-recombinase-expressing
mice deleted the neomycin resistance cassette (neo) between loxP sites (bottom). Asterisk: stop codon of the coding sequence; black thick lane: TAP tag sequence;
triangle: loxP site. (C) PCR genotyping of TAP-tagged PSD-95 mice, using a common forward primer PSD-95 F5 and two reverse primers PSD-95 R6 and pneoR4,
which amplify the wild type (upper band) and targeted allele (lower band), respectively. (D) Immunoblot with PSD-95 antibody for immunoprecipitations. Three different
heterozygous mice are shown (PSD-95TAP/þ , left panel). PSD-95TAP/þ forebrain was also affinity purified with a FLAG antibody (right panel). (E) PSD-95 protein
expression in wt and PSD-95TAP/TAP mouse forebrains. Brain lysates of 5, 10 and 15 mg were loaded and immunoblotted with antibodies against PSD-95 (upper panel)
and tubulin (lower panel), which is a loading control. Wt, wild type; PSD-95TAP/TAP, homozygous TAP-tagged PSD-95 mice; c-, PCR water; IgG, mouse total IgG used as
a negative control of the immunoprecipitation.
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PSD-95TAP/TAP and wt mice. The specific subcellular localiza-
tion of PSD-95 to the postsynaptic compartment of synapses
(dendritic spines) was monitored using postsynaptic markers
for glutamate neurotransmitter receptors (GluR1 or NR1),
presynaptic marker (synaptophysin) and dendritic markers
(MAP2) (Figure 2B and Supplementary Figure 1). Similar to
PSD-95 staining in wt neurons, TAP-tagged PSD-95 was
localized to punctate structures along the length of dendrites
in PSD-95TAP/TAP neurons (Figure 2C, top panels). FLAG
staining also shows the punctate structures in PSD-95TAP/TAP
neurons (Figure 2C, bottom panels). Synaptophysin staining
shows typical juxtaposition, indicating that TAP-tagged
PSD-95 is found at synapses in PSD-95TAP/TAP neurons
(Supplementary Figure 1, top panels). Furthermore, the
co-localization of GluR1 and NR1 subunits with TAP-tagged
PSD-95 (Supplementary Figure 1, middle and bottom panels,
respectively) confirms its postsynaptic localization in the
excitatory synapses, just as occurs for wt PSD-95.
The TAP tag does not affect the synaptic
electrophysiology
Knockout mutations or overexpression of PSD-95 results in
striking changes in synaptic physiology (Migaud et al, 1998;
El-Husseini et al, 2000; Beique et al, 2006). In particular, long-
term potentiation (LTP) of the excitatory synaptic transmission
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Figure 2 Analysis of TAP-tagged PSD-95 localization and synaptic plasticity in PSD-95TAP/TAP mice. (A) Immunohistochemical staining of PSD-95 in sagittal brain
sections from PSD-95TAP/TAP and wt mice. B, brainstem; C, cortex; CB, cerebellum; H, hippocampus; S, striatum. Scale bar¼1mm. (B) Immunohistochemical staining
of PSD-95 in sagittal hippocampus sections from PSD-95TAP/TAP and wt mice showing CA1, CA3 and dentate gyrus (DG). Scale bar¼1mm. (C) Synaptic localization of
TAP-tagged PSD-95 in primary hippocampus neurons. DIV14 neurons from wt and PSD-95TAP/TAP mice were stained with PSD-95 and MAP2B antibodies (top panels).
Three lower panel show PSD-95 and FLAG antibody staining in a culture from PSD-95TAP/TAP mice (bottom panels). Inset panels show higher magnification of synaptic
puncta labeling with each antibody and merged image. Scale bar¼10 mm. (D) Long-term potentiation of fEPSPs induced by theta-burst stimulation in CA1 area of
hippocampal slices is similar in PSD-95TAP/TAP (13 slices from 4 animals) and wild-type mice (15 slices from 4 animals).
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is greatly enhanced in PSD-95 knockout mice (Migaud et al,
1998; Komiyama et al, 2002; Beique et al, 2006). To determine
whether TAP tagging of PSD-95 also altered the synaptic
physiology, we studied short- and long-term plasticity in
hippocampal slices of PSD-95TAP/TAPmice (Figure 2D). A short
episode of theta-burst stimulation was used to induce LTP of
field extracellular post-synaptic potentials (fEPSPs) in the CA1
area of the hippocampus. In the period of 60–65min after
theta-burst stimulation, amplitudes of fEPSPs in the test
pathway normalized relative to control pathway were not
different between PSD95TAP/TAP and wt mice (194±15%
versus 176±8%; P¼0.295) (Figure 2D). Likewise, paired-
pulse facilitation, an established measure of short-term
plasticity, was similar in wt and PSD-95TAP/TAP animals
(Supplementary Figure 2), whereas it is known that this
parameter is significantly enhanced in PSD-95 knockout mice
(Migaud et al, 1998; Beique et al, 2006). Therefore, we
conclude that the engineering of the TAP tag into PSD-95 using
the knockin strategy has not altered the synaptic physiological
function of PSD-95. Together, the physiological, biochemical,
tissue and subcellular localization studies indicate that the
presence of the TAP tag did not significantly alter the
expression or function of PSD-95.
Optimization of single-step and tandem affinity
purification of PSD-95-associated complexes
The following four-stage protocol for isolation of PSD-95
complexes was used (Figure 3A). First, TAP-tagged PSD-95
(from homozygous PSD-95TAP/TAP mice) was captured from
brain extracts with an anti-FLAG antibody covalently coupled
to Dynal beads. Second, the complex was eluted by cleavage
with TEV protease completing the single step of purification.
In the third stage, the complex was recovered from solution by
Ni2þ–NTA–agarose column that binds the HAT-tagged
PSD-95. The fourth and final stage was the release of the
PSD-95 complex from the column using imidazole, completing
the tandem purification.
We examined the efficiency of the different steps in this
protocol bymonitoring PSD-95. All the solubilized PSD-95 was
captured by FLAG-Dynal beads and490% was cleaved using
TEV protease (Supplementary Figure 3A). In the absence of
TEV, there was no spontaneous release of TAP-tagged PSD-95
during incubations (Figure 3B, lane 4, 5 Non-TEV, El lane).
TEV incubation released 50–70% of cleaved PSD-95 (Figure
3B, lane 2, El) and 30–50% of cleaved PSD-95 remained on the
beads (Figure 3B, lane 3, BB). TEV had efficiently cleaved the
retained protein as the size of PSD-95 in the BB lane
corresponded to cleaved TAP-tagged PSD-95, and moreover,
was not recognized by anti-FLAG antibodies on immunoblot-
ting (Supplementary Figure 3A, comparison of BB lanes). This
partial retention of cleaved protein seems to be a protein-
specific phenomenon as we have observed this with other
proteins studied in a similar manner (data not shown). For
other controls, as expected, the FLAG antibody did not
precipitate PSD-95 from wt mouse forebrain (Figure 3B, right
panel). The recovery of PSD-95 using a Ni2þ–NTA–agarose
column that binds the HAT-tagged PSD-95 was very efficient
(495%) (Figure 3C, lanes 2 and 3, TEV El, SN). Subsequent
elution using imidazole was also highly efficient (495%) (no
detectable retained-PSD-95 in BB lane, Figure 3C). Overall, we
estimate that the yield of the protein recovery was 50–60% of
the total PSD-95 present in the brain lysate.
Characterization of TAP-tagged
PSD-95-associated complexes
We next examined the components of PSD-95 complexes and
compared the single-step purification with the tandem
purification. Complexes from PSD-95TAP/TAP and wt mice were
subjected to SDS–PAGE and stained with colloidal Coomassie
for band visualization before gel lanes were cut into slices
(Figure 3D). These gels show a strong 95–100 kDa band in the
PSD-95TAP/TAP lanes that corresponds to TAP-tagged PSD-95
and was absent in purifications from wt mice. A total of
301 different proteins were identified by LC-MS/MS from
PSD-95TAP/TAP in all single-step and tandem purifications
(Supplementary Tables 1 and 2).
Toward identifying ‘core’ complexes, we found 118 (39% of
301) proteins in three of four independent tandem purifica-
tions (a total of 158 proteins were found in all four tandem
purification experiments) (Figure 3E and Tables I and II). The
tandem purification has a significant technical advantage
because abundant proteins (present in single step) ‘mask’ less
abundant proteins that appear after further purification (Wang
et al, 2006).We found 71 (45%) out of the 158 proteinsmasked
in the single purification. This is shown in the Venn diagram
(Figure 3F). We created a Web source that provides access to
this data and links to physiological and behavioral data from
knockout mice for the respective genes (www.genes2cognition.
org/TAP-PSD-95).
To further explore the advantages of the TAP method, we
examined the specific proteins to identify new PSD-95
interactors and also compared the types of proteins remaining
in the core set after tandem purification. From the core complex
of 118 proteins, 26 (22%) were reported as primary interactors
(data present in HPRD, Biogrid, BIND and HOMOMINT
databases) and included membrane-associated guanylate ki-
nases (MAGUK or disc large homolog, Dlg family), NMDA
receptor subunits, potassiumchannels and cytoskeletal proteins
(Supplementary Table 3). Using immunoblotting we confirmed
the presence of 13 PSD-95 interactors (Supplementary Figure
3B). Ten of those interactors were examined by reverse
immunoprecipitation and all were validated (Supplementary
Figure 3C). We also examined four new interactors using co-
immunoprecipitation experiments: Arc/Arg3.1, Rac1, Nsf and
Ablim1 (Figure 4 and Supplementary Figure 3B). These proteins
are involved in cytoskeletal, vesicular-trafficking and G-protein-
mediated signaling pathways.
We used two methods to examine the types of proteins
enriched by the tandem procedure. In the first approach, we
grouped all proteins from both single-step and tandem
purifications into ten functional categories and graphed the
numbers of proteins in each category as a percentage of the
dataset (Supplementary Figure 4). The tandem purification
was enriched in channels/receptors, cytoskeletal/structural/
adhesion and adaptors/regulatory proteins. There was a
striking depletion of enzymes in the tandem purification
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comparedwith the single-step purification, consistent with the
fact that many metabolic enzymes are abundant and can
contaminate such purifications (Chen and Gingras, 2007). In
the second approach, we considered the emPAI values (a
semiquantitative measure of protein abundance based on MS
data) for the 301 proteins and divided the dataset into two
groups: tandem enriched and tandem depleted (Supplemen-
tary Table 4 and Supplementary Figure 5). Analysis of Gene
Ontology (GO) terms showed that the tandem depleted set was
significantly over-represented with the following GO terms:
metabolism (P¼1.67e3), cytoplasm (P¼2.10e5) and mito-
chondrion (P¼7.96e4). In contrast, the tandem enriched set
was significantly enriched with the following GO terms: signal
transducer activity (P¼6.16e6), synapse (P¼3.52e7), post-
synaptic membrane (P¼3.22e5) and cell communication
(P¼2.33e5). Thereforewe conclude that the TAP strategy can
be used to recover a smaller and more specific subset of
proteins than a single immunoaffinity (FLAG antibody)
procedure.
We compared the lists of proteins identified in the TAP
experiments with earlier studies of synapse proteomes
(Supplementary Tables 1 and 5). An earlier report using a
single immunoprecipitation with a PSD-95 antibody identified
276 proteins from PSD fractions extracted in the absence of
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Table I Functional classification of PSD-95-associated proteins in at least three out of four tandem purifications
MGI symbol Protein name UniProt Acc Number of peptides Cluster
T1 T2 T3 T4
Adaptor/regulatory
Anks1 Ankyrin repeat and SAM domain containing 1 P59672 4 3 3
Anks1b Ankyrin repeat and sterile alpha motif domain containing 1B Q8BZM2 17 5 10 10
Baiap2 Brain-specific angiogenesis inhibitor 1-associated protein 2 Q8BKX1 20 12 13 13 d
Begain Brain-enriched guanylate kinase-associated Q68EF6 4 8 12 16 a
Dlg1 Synapse-associated protein 97 Q3UP61 24 42 34 42 a
Dlg2 Postsynaptic density protein 93 Q91XM9 49 67 69 80 a
Dlg3 Synapse-associated protein 102 Q52KF7 27 17 14 22 a
Dlg4 Postsynaptic density protein 95 Q62108 42 57 64 64 a
Dlgap1 SAP90/PSD-95-associated protein 1 Q9D415 11 9 14 24 a
Dlgap2 SAP90/PSD-95-associated protein 2 Q8BJ42 18 12 19 24 a
Dlgap3 SAP90/PSD-95-associated protein 3 A2A7T7 16 8 7 15 a
Dlgap4 SAP90/PSD-95-associated protein 4 A2BDU3 14 9 7 14 a
Receptor/channels/transporters
Gria1 Glutamate receptor, ionotropic, AMPA 1 Q5NBY1 2 3 5 13 b
Gria2 Glutamate receptor, ionotropic, AMPA 2 P23819 4 8 10 20 b
Gria3 Glutamate receptor, ionotrophic, AMPA 3 Q9Z2W9 2 9 18 b
Gria4 Glutamate receptor, ionotrophic, AMPA 4 Q9Z2W8 2 2 5 9 b
Grik2 Glutamate receptor, ionotropic, kainate 2 (beta 2) P39087 2 4 6 b
Grik5 Glutamate receptor, ionotropic, kainate 5 (gamma 2) Q61626 2 3 7 b
Grin1 Glutamate receptor, ionotropic, NMDA1 (zeta 1) A2AI21 29 40 50 55 a
Grin2a Glutamate receptor, ionotropic, NMDA2A (epsilon 1) P35436 24 31 36 46 a
Grin2b Glutamate receptor, ionotropic, NMDA2B (epsilon 2) Q01097 44 54 67 78 a
Grin2d Glutamate receptor, ionotropic, NMDA2D (epsilon 4) Q03391 3 6 9 10 a
Gpr123 G protein-coupled receptor 123 Q52KJ6 2 3 3 3
Cacng2 Calcium channel, voltage-dependent, gamma subunit 2 O88602 2 2 2 3 b
Kcna1 K+ voltage-gated channel, shaker-related subfamily, member 1 P16388 6 5 5 6 c
Kcna2 K+ voltage-gated channel, shaker-related subfamily, member 2 P63141 4 5 7 6 c
Kcna3 K+ voltage-gated channel, shaker-related subfamily, member 3 P16390 3 4 6 5 c
Kcna4 K+ voltage-gated channel, shaker-related subfamily, member 4 Q8CBF8 2 3 5 5 c
Kcnab1 K+ voltage-gated channel, shaker-related subfamily, beta member 1 P63143 3 3 4 6 c
Kcnab2 K+ voltage-gated channel, shaker-related subfamily, beta member 2 P62482 5 6 10 11 c
Kcnj10 K+ inwardly-rectifying channel, subfamily J, member 10 Q9JM63 3 3 4 6 a
Kcnj4 K+ inwardly-rectifying channel, subfamily J, member 4 P52189 4 6 6 8 a
Vdac1 Voltage-dependent anion channel 1 Q60932 4 4 5 5 f
Vdac2 Voltage-dependent anion channel 2 Q60930 4 2 3 4
Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide1 P14094 3 3 6 3
Atp6v0d1 ATPase, H+ transporting, V0 subunit d isoform 1 P51863 3 3 4 2
Sfxn3 Sideroflexin 3 Q91V61 3 3 4 3
Slc1a2 Solute carrier family, member 2 P43006 3 2 4 4
Slc25a4 ADP/ATP translocase 1 P48962 2 3 6 g
Slc25a5 ADP/ATP translocase 2 P51881 2 2 3 6 g
Slc4a4 Solute carrier family 4 (anion exchanger), member 4 O88343 3 6 4
Cytoskeletal/structural/cell adhesion
Ablim1 Actin-binding LIM protein 1 Q8K4G5 20 10 18 22
Adam22 a disintegrin and metallopeptidase domain 22 Q9R1V6 12 16 24 31 e
Arc Activity regulated cytoskeletal-associated protein Q9WV31 8 13 20 19
Arpc4 Actin related protein 2/3 complex, subunit 4 P59999 2 2 4
Capza2 Capping protein (actin filament) muscle Z-line, alpha 2 P47754 2 2 2
Cfl1 Cofilin 1, non-muscle P18760 2 2 3 4
Dstn Destrin Q9R0P5 2 5 6 6
Fscn1 Fascin homolog 1, actin bundling protein
(Strongylocentrotus purpuratus)
Q61553 2 2 3 f
Lgi1 Leucine-rich repeat LGI family, member 1 Q9JIA1 6 12 19 15 e
Nefl Neurofilament, light polypeptide 68kDa P08551 3 3 6 a
Nrxn1 Neurexin 1 Q9CS84 8 17 12 23
Plp1 Proteolipid protein (myelin) 1 P60202 2 3 4 5
Sept11 Septin 11 Q8C1B7 2 2 2 2
Sept5 Septin 5 Q9Z2Q6 2 2 4
Spnb2 Spectrin beta 2 Q62261 2 2 5 a
Tuba1a* Tubulin, beta polypeptide P05213, 11 14 20 20
Tubb2b* Tubulin, beta 2b Q7TMM9 19 21 24 27
Tubb6 Tubulin, beta 6 Q922F4 8 8 13 13
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Table I Continued
MGI symbol Protein name UniProt Acc Number of peptides Cluster
T1 T2 T3 T4
Vesicular/trafficking/transport
Arf3 ADP-ribosylation factor 3 P61205 2 2 3 4
Cltc Clathrin, heavy chain (Hc) Q5SXR6 10 4 12 a
Cpne4* Copine IV Q8BLR2 4 2 3
Cpne7 Copine VII7 Q0VE82 4 3 2 3
Iqsec1 IQ motif and Sec7 domain 1 Q8R0S2 11 7 6 15
Iqsec2 IQ motif and Sec7 domain 2 Q5DU25 34 25 24 36
Nsf N-ethylmaleimide sensitive fusion protein P46460 4 4 7 9
Stx1b2 Syntaxin 1B2 P61264 3 4 3 2
Stxbp1 Syntaxin binding protein 1 O08599 5 3 4 4
Syt1 Synaptotagmin I P46096 5 2 2 2
Vamp2* Synaptobrevin 2 P63024 2 4 2
Enzymes
Acat1 Acetyl-Coenzyme A acetyltransferase 1 Q8QZT1 2 3 3
Aco2 Aconitase 2, mitochondrial Q99KI0 3 3 2
Acot7 Acyl-CoA thioesterase 7 Q91V12 3 3 3 4
Aldoc Aldolase C, fructose-bisphosphate P05063 4 2 4
Atp5c1 ATP synthase, H+ transporting, mitochondrial F1 complex,
gamma polypeptide 1
Q91VR2 3 3 4 g
Atp5b ATP synthase, H+ transporting mitochondrial F1 complex,
beta subunit
P56480 2 6 5 g
Atp5o ATP synthase, H+ transporting, mitochondrial F1 complex,
O subunit
Q9DB20 2 2 4 4 g
Atp5a1 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha
subunit, isoform 1
Q03265 5 10 14 11 g
Cnp 20,30-cyclic nucleotide 30 phosphodiesterase P16330 10 3 11 10
Gapdh Glyceraldehyde-3-phosphate dehydrogenase P16858 9 8 9 10 f
Gda Guanine deaminase Q9R111 29 26 29 31 a
Glul Glutamate–ammonia ligase (glutamine synthetase) P15105 5 17 21 19
Gpx4 Glutathione peroxidase 4 O70325 2 2 2
Msrb2 Methionine sulfoxide reductase B2 Q78J03 2 7 4
Pdha1 Pyruvate dehydrogenase E1 alpha 1 P35486 4 3 8 5
Pdhb Pyruvate dehydrogenase (lipoamide) beta Q9D051 4 4 4 6
Pgk1 Phosphoglycerate kinase 1 P09411 2 3 13 8 f
Pkm2 Pyruvate kinase, muscle P52480 7 6 11 12
Ppap2b Phosphatidic acid phosphatase type 2B Q99JY8 2 2 5
Prdx1 Peroxiredoxin 1 P35700 4 7 10 14
Prdx2 Peroxiredoxin 2 Q61171 2 2 3
Sdha Succinate dehydrogenase complex, subunit A, flavoprotein (Fp) Q8K2B3 7 6 8 6
Sucla2 Succinate-CoA ligase, ADP-forming, beta subunit Q9Z2I9 4 2 5 6
Kinases
Camk2a Calcium/calmodulin-dependent protein kinase II alpha P11798 11 3 4 11 a
Camk2b Calcium/calmodulin-dependent protein kinase II beta Q5SVI3 10 5 5 7 a
Mapk1 Mitogen-activated protein kinase 1 P63085 3 3 4 9
Phosphatases
Ppap2b Phosphatidic acid phosphatase type 2B Q99JY8 2 2 5
Ppp3ca Protein phosphatase 3, catalytic subunit, alpha isoform P63328 12 6 7 11 a
Ppp3cb Protein phosphatase 3, catalytic subunit, beta isoform P48453 7 3 2 4
G-protein signaling
Abr Active BCR-related gene Q6PCY1 2 2 6
Gnao1 Guanine nucleotide binding protein, alpha o P18872 8 7 15 16
Kalrn Kalirin, RhoGEF kinase A2CG52 2 3 2 8
Rac1 RAS-related C3 botulinum substrate 1 Q3TLP8 2 2 3 3 d
Syngap1 Synaptic Ras GTPase activating protein 1 homolog (rat) Q9QUH6 21 15 17 38 a
Transcription/translation
Park7 Parkinson disease (autosomal recessive, early onset) 7 A2A817 3 3 3
Rps14 Ribosomal protein S14 P62264 2 3 2
Rps3 Ribosomal protein S3 P62908 2 3 4
Uba52* Ubiquitin A-52 residue ribosomal protein fusion product 1 Q66JP1 3 3 5 6
Signal transduction
Btbd11 BTB (POZ) domain containing 11 Q6GQW0 5 3 2 3
Phb2 Prohibitin 2 O35129 2 5 4
Ywhae Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation
protein, epsilon polypeptide
P62259 3 2 2
Pcbp1 Poly(rC) binding protein 1 P60335 3 3 5
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detergent (Dosemeci et al, 2007). The comparison of this list
with the PSD-95 core complexes of 118 proteins reported here
shows 49 proteins in common. A peptide affinity method for
binding PDZ domains of MAGUK proteins (Husi et al, 2000;
Husi and Grant, 2001; Collins et al, 2005; Emes et al, 2008) was
used in the same extraction conditions reported here and
recovered 105 proteins (Collins et al, 2005). This peptide
affinity method was not specific to PSD-95 as the peptides are
known to bind PSD-93 and SAP102 (Lim et al, 2002; Chung
et al, 2004). These 105 proteins and the proteins found by
NMDA-receptor immunopurification were used to generate a
list of 186 MASC proteins (Collins et al, 2006). Comparison of
our 118 PSD-95 TAP list with the 186 proteins from the MASC
complex shows 48 proteins in common (Supplementary Tables
1 and 5). An important set of proteins that was recovered using
the TAPmethod consisted of the AMPA (a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid) receptors and Kþ channels,
which is discussed below. Overall we conclude that the
targeted TAP tagging allowed for the enrichment of crucial
synaptic proteins.
Composition and organization of PSD-95
interaction networks
To explore the functional organization of the PSD-95 com-
plexes, we reconstructed a network using protein–protein
interaction data from high-quality manually-curated interac-
tion data (Pocklington et al, 2006) and the UniHi database
(http://www.mdc-berlin.de/unihi). After manual curation,
we identified 119 interactions between 50 proteins (excluding
self-interactions) from the 118 proteins in the PSD-95 core
complex (Table I). No binary interactions were found for the
remaining 68 proteins.
Network clustering of the interacting proteins showed 40 out
of the 50 proteins formed a large connected component (major
connected component, MCC) and amodular structure that was
segregated into five clusters (see Materials and methods),
referred to as cluster a (Cla) to cluster e (Cle) (Figure 5A). In
addition to the five MCC clusters, two further disconnected
clusters (‘Clf’ and ‘Clg’) were found (see Table I for details).
It is interesting to note the location and proximity of the
receptors and channels responsible for the postsynaptic
depolarization and subsequent action potential generation.
All NMDA, AMPA and kainate glutamate receptors were
restricted to Cla and Clb and the voltage-dependent Kþ
channels were found in Cla and Clc (entirely comprised of
Kþ channels). These channels are known to couple to
plasticity mechanisms (Watanabe et al, 2002; Chen et al,
2006a; Kim et al, 2007), and we noted that Cla contains
important signaling enzymes involved in plasticity, including
CamKII (Frankland et al, 2001) and SynGAP (Komiyama et al,
2002). It therefore seems that Cla, Clb and Clc are enriched
with membrane proteins responsible for the electrical proper-
ties of the postsynaptic terminal.
As PSD-95/Dlg4 was the bait for the biochemical isolation of
the complexes, we examined the distribution of its primary
interactors (proteins that directly bind PSD-95) and secondary
interactors (proteins that do not bind PSD-95 directly, but bind
one of its primary interactors) (Figure 5A). Of the 39 MCC
proteins (excluding PSD-95), 26 (67%) were primary inter-
actors (blue symbols in Figure 5A) and 12 (31%) were
secondary interactors (yellow symbols in Figure 5A) and only
one protein, the AMPA receptor subunit Gria3, was a tertiary
interactor. The majority of each cluster of the MCC comprised
primary interactors: Cla (74%), Clb (43%), Clc (67%), Cld
(50%) and Cle (50%). To examine the centrality of each
protein in the network the shortest path from each protein to
every other proteinwas counted, and the average shortest path
(ASP) calculated. For all proteins, the mean ASP was 2.25.
Ranking the ASP of each protein (Supplementary Table 6)
showed PSD-95 had the lowest ASP (1.3), consistent with its
central role in these networks.
It was of interest to compare the PSD-95 network (MCC of 40
proteins) with the previously published MASC network (MCC
of 90 proteins) that was built fromproteins co-purifiedwith the
NMDA receptor complex and with the PDZ peptide affinity
method described in the previous section (Pocklington et al,
Table I Continued
MGI symbol Protein name UniProt Acc Number of peptides Cluster
T1 T2 T3 T4
Unclassified
Fam81a Family with sequence similarity 81, member A Q3UXZ6 7 6 21 18
AI662250 Expressed sequence AI662250 Q3UKV2 2 2 2
B630019K06Rik RIKEN cDNA B630019K06 gene Q7TNS5 6 7 8 9
Frmpd3 FERM and PDZ domain containing 3 Q8BXG0 2 5 5
Pgam5 Phosphoglycerate mutase family member 5 Q3UK19 7 7 8 10
Prrt1 Proline-rich transmembrane protein 1 O35449 2 2 2 3
Slc9a3r1 Solute carrier family 9 (sodium/hydrogen exchanger),
member 3 regulator 1
P70441 4 3 7 2
MGI approved gene symbols and protein names, and UniProt accession numbers are shown. Numbers of approved peptides for each protein identified by LC-MS/MS in
the four tandem purifications are indicated as T1, T2, T3 and T4. More information regarding these proteins is given in Supplementary Table 1. Genes marked with an
asterisk represent genes whose peptides are common to other genes.
Cpne4*: Cpne5, Cpne8.
Tuba1a*: Tuba1b, Tuba4c, Tuba1b.
Tubb2b*: Tubb5, Tubb2a, Tubb2c, Tubb4.
Uba52*: Ubc, Ubb.
Vamp2*: Vamp3.
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Table II Functional classification of PSD-95-associated proteins in one or two tandem purifications
MGI Symbol Protein name UniProt Acc Number of peptides
T1 T2 T3 T4
Adaptor/regulatory
Ap2a1 Adaptor protein complex AP-2, alpha 1 subunit P17426 3
Grb2 Growth factor receptor bound protein 2 Q60631 2 4
Receptors/channels/transporters
Atp2b1 ATPase, Ca++ transporting, plasma membrane 1 Q05CJ5 2 4
Grin2c Glutamate receptor, ionotropic, NMDA2C (epsilon 3) Q01098 5
Grm3 Glutamate receptor, metabotropic 3 Q9QYS2 2
Kcnj16 Potassium inwardly-rectifying channel, subfamily J, member 16 Q9Z307 7
Lrp1 Low density lipoprotein receptor-related protein 1 Q91ZX7 2 3
Lrrtm1 Leucine rich repeat transmembrane neuronal 1 Q8K377 2
Slc1a3 Sodium-dependent glutamate/aspartate transporter 1 P56564 3 3
Slc2a1 Solute carrier family 2 (facilitated glucose transporter), member 1 P17809 2 2
Vdac3 Voltage-dependent anion channel 3 Q60931 2 5
Cytoeskeletal/structural/cell adhesion
Mtap1a Microtubule-associated protein 1 A Q9QYR6 3 2
Nlgn2 Neuroligin 2 Q69ZK9 2
Nlgn3 Neuroligin 3 A2AGI2 2
Syn2 Synapsin II Q64332 3 4
Shank1 SH3/ankyrin domain gene 1 XP_001474960a 4
Enzymes
Cit Citron P49025 11
Crym Crystallin, mu O54983 3 3
Csmd2 CUB and Sushi multiple domains 2 A2A8D7 5
Dusp10 Dual specificity phosphatase 10 Q8R3L3 3 2
Jak3 Janus kinase 3 Q62137 2
Mapk3 Mitogen activated protein kinase 3 Q63844 4
Ube2v1 Ubiquitin-conjugating enzyme E2 variant 1 Q9CZY3 2 5
Ube2v2 Ubiquitin-conjugating enzyme E2 variant 2 Q9D2M8 2 4
G-protein signalling
Gna13 Guanine nucleotide binding protein, alpha 13 Q8C5L2 2 2
Gnb1 Guanine nucleotide binding protein (G protein), beta 1 P62874 3 3
Rab6 RAB6, member RAS oncogene family P35279 4
Signalling
Fbxo2 F-box protein 2 Q80UW2 4
Fbxo6 F-box protein 6 Q9QZN4 3 4
Nxph3 Neurexophilin 3 Q91VX5 2
Pcbp2 Poly(rC) binding protein 2 Q61990 3 3
Traf3 Tnf receptor-associated factor 3 Q3UHJ1 3 3
Chaperone/protein folding/signalling
Hspa12a Heat shock protein 12A Q8K0U4 2
DNA binding
Hist1h2bj* Histone 1, H2bb Q8CGP2 3 3
Transcription/translation
Eef1a1* Eukaryotic translation elongation factor 1 alpha 1 P10126 2 2
Lsm11 U7 snRNP-specific Sm-like protein LSM11 Q8BUV6 2 3
Unclassified
Clu Clusterin Q06890 2 3
Lancl1 LanC (bacterial lantibiotic synthetase component C)-like 1 O89112 4
Mog Myelin oligodendrocyte glycoprotein Q61885 2 2
Neto1 Neuropilin (NRP) and tolloid (TLL)-like 1 Q8R4I7 2 2
MGI approved gene symbols and protein names, and UniProt accession numbers are shown. Number of approved peptides for each protein identified by LC-MS/MS in
the four tandem purifications is indicated as T1, T2, T3 and T4. More information of these proteins is listed in Supplementary Table 1. Genes marked with an asterisk
represent genes whose peptides are common to other genes.
aNCBI accession number.
Eif1a1*: Eif1a2.
Hist1h2bj*: Hist1h2bm, Hist1h2be, Hist1h2bn, Hist1h2bg, Hist1h2bp, Hist1h2bh, Hist1h2bf, Hist1h2bb, Hist3h2bb, Hist1h2bc, Hist1h2bl, Hist2h2bb.
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2006). The MASC MCC had 13 clusters, with cluster 1
containing PSD-95 (Supplementary Figure 6). A total of 16
proteins were common to PSD-95 MCC and MASC MCC
(Po10e7) and with overlap centered (10/16 proteins,
Po10e3) on Cla and MASC cluster 1. In contrast to MASC
MCC, the PSD-95 MCC had Clb (AMPA receptors) and Clc
(Kþ channels).
Psychiatric disorders and PSD-95 complexes
To explore the potential medical importance of the 118 core
PSD-95 interactome we asked (i) which diseases are these
proteins involved with, and (ii) is there any relationship
between the network clusters and disease types. For each of
the proteins in the 118 core set, we manually curated
information on their disease involvement from the literature.
A total of 49 genes were implicated in multiple diseases:
schizophrenia (28), mental retardation (6), bipolar disorder
(13) Alzheimer’s disease (6) and others (29) (Table III).
We next analyzed the pair-wise correlation between func-
tional categories (Tables I and II) and disease type. The
‘receptors/channels/transporters’ category and ionotropic
glutamate receptors were significantly correlated with schizo-
phrenia (P¼0.0024 and Po10e6, respectively). Out of 28
schizophrenia-implicated proteins, 20 were mapped into the
network model (orange in Figure 5B). Of those 20 proteins,
70% fell into Cla, which was significantly enriched in
schizophrenia-related proteins (P¼0.0089). All but one of the
remaining schizophrenia-related proteins were found in
cluster Clb.
Discussion
Here we report the first isolation of multiprotein complexes
from mice using a knockin of a TAP tag fused with the
endogenous protein. This allowed expression of the tagged
protein to be controlled by its endogenous regulatory
elements. A stable and specific complex of 118 proteins
associated with PSD-95, containing a range of important
synaptic receptors, channels and signaling molecules, includ-
ing new interactors was isolated.
Previous use of TAP tagging in mammalian cells and tissues
was limited to expression of exogenous tagged cDNAs
(Knuesel et al, 2003; Bouwmeester et al, 2004; Brajenovic
et al, 2004; Drakas et al, 2005;Wang et al, 2005, 2006; Angrand
et al, 2006; Burckstummer et al, 2006), which do not
recapitulate the natural expression of the protein. A TAP
insertion using homologous recombination was published by
Chen et al, however, purification of complexes was not
reported from mouse tissue (Chen et al, 2006b). In addition
to the advantage of recapitulating the natural expression of the
protein, and thereby limiting artefactual interactions, the
targeting of the endogenous gene allows the breeding of the
mice to homozygosity. This permits testing the possibility that
the insertion created a mutation. We found no evidence of a
mutant phenotype as neither the level, tissue expression
pattern, subcellular localization or synaptic physiology of
PSD-95 was found in homozygous mice.
The two consecutive steps of purification in the TAP
protocol offer advantages over single-step methods such as
immunoprecipitation, which is the most commonly used
approach. Immunoprecipitation is limited by (i) availability of
suitable antibodies and their cross reaction with other
proteins, (ii) the possibility that the antibody–protein interac-
tion might be affected by either post-translational modifica-
tions or by the binding with other proteins, (iii) the antibody
might disrupt interacting partners, (iv) the harsh conditions
for the complex elution might result in protein degradation. In
addition to overcoming these limitations, the TAP procedure
offers an efficient method for isolation of native complexes.
Also, we observed that the two-step procedure unmasked core
interacting proteins that were not detected by mass spectro-
metry in the single-step purification: Ten known PSD-95
interactors, Begain, Cit, Grik2, Grik5, Grin2c, Kcna4, Lrp1,
Nlgn2, Nlgn3 and Shank1, were present only after the tandem
purification. Furthermore, we found 21 new proteins in the
PSD-95 core complexes that were not reported in earlier PSP
proteomic analysis (Collins et al, 2006 [19]Dosemeci et al,
2007) (Supplementary Table 1), again suggesting that the
targeted TAP-tagging strategy produces greater depth and
quality of interactors.
The fact that PSD-95-associated complexes contain iono-
tropic glutamate receptors of the NMDA, AMPA and kainate
subtypes as well as major Kþ channels is of considerable
technical and biological significance. These proteins are the
major postsynaptic constituents responsible for synaptic
transmission and shaping the postsynaptic electrophysiological
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Figure 4 Validation of new PSD-95 interaction partners. Immunoprecipitation
from forebrain extracts with indicated antibodies (labeled above panels) and
immunoblotting with antibodies directed against specific proteins (labeled on the
right side of each panel). Antibodies against PSD-95, Nsf, Rac1 and Ablim were
used for immunoblotting. Protein molecular weight (kDa) on left. PSD-95
interaction with Arc/Arg3.1 is shown in Supplementary Figure 3B. C-, mouse total
IgG was used for immunoprecipitation control; IP, antibodies used for
immunoprecipitation; lc, antibody light chain.
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response to presynaptic input. We also believe that this is the
first method that allows the robust co-purification of these
proteins and that the PSD-95TAPmicewill be a valuable tool for
studying the postsynaptic terminal in vivo. These applications
will extend to physiological and behavioral studies of many
regions of the brain and disease models.
Although PSD-95 is a known direct binding partner of
NMDA receptors, there is conflicting data about physical
interactions between PSD-95 and AMPA receptor subunits.
PSD-95 expression affects AMPA receptor-mediated excitatory
synaptic transmission (Migaud et al, 1998; Beique et al, 2006;
Carlisle et al, 2008) and is thought to involve indirect
interactions through stargazin, SAP-97, Adam22, Lgi1 and
Nsf (Leonard et al, 1998; Osten et al, 1998; Fukata et al, 2006).
As we show using reciprocal co-precipitation, the interaction
of PSD-95 with N-ethylmaleimide sensitive fusion protein
Figure 5 Protein interaction network of PSD-95 interacting proteins. (A) 50 proteins of the PSD-95 core complex were connected, with 119 interactions segregated
into 5 clusters (Cla–Cle) forming the MCC and two separate small clusters Clf and Clg. PSD-95/Dlg4 is showed in red, primary interactors of PSD-95/Dlg4 are shown in
blue and secondary interactors are shown in yellow. The glutamate receptors (NMDA, AMPA and kainate receptors) and potassium channels are bracketed.
(B) Schizophrenia susceptibility genes are shown in orange.
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(NSF), a cytosolic ATPase, was required for intracellular
membrane fusion, and this reinforces the idea of PSD-95
involvement in synaptic vesicle trafficking and AMPA surface-
expression modulation (Luthi et al, 1999; Noel et al, 1999).
Other proteins involved in the trafficking and clustering of
AMPA receptor are Arc/Arg3.1 (Chowdhury et al, 2006;
Shepherd et al, 2006) and Rac1 (Wiens et al, 2005), and these
were found within the complexes. The isolation of multiple
AMPA-receptormodulators in the PSD-95 complexes underlines
the importance of this complex in mediating synaptic plasticity.
We annotated the disease involvement of the proteins in the
PSD-95 complexes as a step toward using this proteomic data
to drive human genetic studies.We identified 49 of the proteins
as involved with human mental disorders, of which there was
a high representation of cognitive disorders. Nineteen genes
involved in schizophrenia were significantly associated with
the clusters Cla and Clb that contain all the glutamate receptors
and MAGUK/Dlg proteins. Mapping the primary interactors of
these schizophrenia proteins recruited many other proteins
found in the other modules of the network. This suggests that
the overall network and its various clusters might play a role in
schizophrenia, and not simply the glutamate receptors, as was
generally considered in the ‘glutamate hypothesis’ of schizo-
phrenia (Greene, 2001; Coyle, 2006; Lisman et al, 2008).
Proteomic studies are likely to be useful for driving high-
throughput sequencing in human diseases and aid in medical
systems biology.
Materials and methods
Vector generation and gene targeting
The TAP tag was constructed by assembling two PCR fragments
containing histidine affinity tag (HAT), TEV protease and FLAG
Table III Genes associated with neurological and psychiatric diseases
MGI symbol Disease MGI symbol Disease
Adam22 Epilepsy1 Grin2d Schizophrenia2
Acot7 Schizophrenia3 Kcnj4 Schizophrenia4
Atp1b1 Rett syndrome5 Kcna1 Episodic ataxia, type 16
Neurodegeneration7 Kcnj10 Epilepsy8
Atp5a1 Alzheimer’s9 Seizure10
Atp5c1 Bipolar affective disorder11,12 Lgi1 Epilepsy1
Cacng2 Bipolar disorder13 Mapk1 Schizophrenia15,16
CamKIIa Bipolar disorder14 Depression18
CamKIIb Schizophrenia17 Msrb2 Bipolar afective disorder11
Depression17
Capza2 Mental retardation19 Nefl CMT120
Cltc Mental retardation21 Schizophrenia3
Cnp1 Schizophrenia3,22 Bipolar23
Dlg1 Schizophrenia24 CMT225,26
Dlg2 Schizophrenia22 ALS27,28
Dlg3 Schizophrenia23,24 Nrxn1 Autism29
Bipolar disorder23 Schizophrenia22
Depression23 Nsf Schizophrenia30
X-Mental retardation31 Pdha1 Depression32
Dlg4 Schizophrenia33 Pgk1 Parkinson’s5
Bipolar disorder23 Mental retardation34
Dlgap1 Schizophrenia35 Bipolar disorder36
Gapdh Alzheimer’s39 Plp1 Pelizaeus–Merzbacher disease38
Gda Schizophrenia37 Depression40
Gnao1 Schizophrenia41 Multiple sclerosis4245
Gria1 Schizophrenia4650 Demyelinating disease5154
Alzheimer’s55–59 Spastic paraplegia60
Epilepsy61,62 Pppp3ca Schizophrenia63
Gria2 Schizophrenia4,64 Prdx1 Alzheimer’s65
Epilepsy66–71 Prdx2 Parkinson’s72
Gria3 Schizophrenia47 Sl1a2 Schizophrenia22
X-Mental retardation73 ALS74
Gria4 Schizophrenia22 Slc25a4 Bipolar afective disorder12
Grik2 Mental retardation75 Ophtalmoplegia76
Schizophrenia22 Stxbp1 Schizophrenia77
Grin1 Attention disorder78 Vdac1 Alzheimer’s9
Bipolar afective disorder80 Schizophrenia3
Schizophrenia81 Bipolar afective disorder12
Seizure82 Vdac2 Bipolar afective disorder12
Grin2a Alzheimer’s83 Ywhae Miller–Dieker lissencephaly85
Huntington disease84
Schizophrenia33
Grin2b Schizophrenia22,23
Bipolar afective disorder86–88
Epilepsy11,89
Huntington disease84,90
Disease association data for proteins in the tandem purificationwere collected from the Genetic Association Database, CiteXplore andmanually curated. References are
provided in Supplementary information.
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sequences. The HAT tagwas amplified by PCR (PCR1) using 1 ng of the
pHAT20 vector (Clontech) as a template with the forward XbaIHATF1
and reverse HATR1 oligos as primers. The 50-end tail of the forward
primer had an XbaI restriction site and the reverse primer had a tail
containing the six-amino-acid linker in the 50-end and the TEV
protease sequences. The FLAG tag was amplified by PCR (PCR2) with
the forward FLAGF1 and reverse BclIFLAGR1 oligos using as a
template 1 ng of the C-terminal p3xFLAG–CMVt14 vector (Sigma).
The 50-end of the forward primer contains the TEV sequence and the
six-amino-acid linker sequence, whereas the reverse primer contains a
BclI restriction site. A third PCR was then carried out with XbaIHATF1
and BclIFLAGR1 oligos and a mix of PCR1 and PCR2 products as a
template. The 30-end of the PCR1 and the 50-end of the PCR2 shared the
six-amino-acid linker and the TEV sequences, allowing both the
fragments to anneal during the third PCR. This fragment (the TAP tag
sequence) was cloned into pneoflox vector between the XbaI and BclI
restriction sites (TAP tag pneoflox vector). Two homology arms of the
genomic PSD-95 sequence were amplified with forward Psd95HAX-
hoIF and reverse Psd95HAXbaIR primers and forward PSD95HAAc-
c65IF and reverse Psd95HABglIIR primers using the BAC bMQ239c12
(Adams et al, 2005) as a template. Both homology arms were cloned
into the TAP tag pneoflox vector, leaving in between the TAP tag
sequence, 2loxP sites, PGK and EM7 promoters, the G418r gene and a
SV40 polyadenylation site. The cassette flanked by two homology
arms was removed and transformed into EL350 E. coli cells containing
a pTargeter vector with the genomic PSD-95 sequence cr11 69851809 to
cr11 69861137 (Ensembl release 47). The cassette was inserted into the
pTargeter vector by recombination (Knuesel et al, 2003). The final
vector containing a 50-end homolog PSD-95 sequence of 6384 bp and a
30-end homology arm of 2946 bp (ENSMUSG00000020886) was
linearized with PvuI enzyme and electroporated into E14 ES cells.
Sixteen neomycin-resistant colonies from 252 were cloned, expanded
and frozen. Genomic DNAwas extracted from all of them and PCRwas
carried out using pneoF3 and Psd95R3 to identify TAP-tagged PSD-95
homologous recombinants. One of the ES-cells-positives clones was
microinjected into C57BL/6 blastocysts and this generated nine
germline chimeras containing 30–70% of targeted cells. These
chimeras were crossed to an MF1 genetic background. Tail DNA from
the litters was extracted and analyzed by PCRwith a 50 Psd95F5 primer
and two 30 pneoR4 and Psd95R6 primers to distinguish the PSD-95 TAP
(þ /) and wild-type alleles (þ /þ ).
Tandem affinity purification
For each independent purification, two forebrains were homogenized
in DOC buffer (50mM Tris pH 9.0, 1% sodium deoxycholate, 50mM
NaF, 20mM ZnCl, 1mM Na3VO4, 2mM Pefabloc SC (Roche) and 1
tablet/10ml protease inhibitor cocktail tablets (Roche)) and clarified
as described earlier (Husi and Grant, 2001). A total of 25mg of protein
was incubated Dynal beads coupled with FLAG antibody for 2 h at 41C.
The resin was washed with three cycles of 15 resin volumes of DOC
buffer and twice with TEV-protease cleavage buffer (Invitrogen). The
tagged protein was cut from the beads by addition of TEV protease and
the protein eluate was collected. The eluate was dialyzed against 2 L of
dialysis buffer (50mM sodium phosphate pH 8.0, 50mM NaCl) at 41C
with constant agitation. After dialysis the supernatant was collected
and added to Ni2þ–NTA–agarose resin (Qiagen) pre-washed thrice
with the dialysis buffer. The coupling was carried out for 40min at 41C
with constant agitation in batch, then collected with supernatant and
packed into 5ml plastic columns (Clontech). After sedimentation, the
supernatant was collected by gravity flow and the resin was washed
thrice with wash buffer containing 0.1% sodium deoxycholate and
1mM of imidazole. The elution was carried out with 750ml of elution
buffer and fractions were recovered.
All imidazole eluted fractions from the tandem purification that
contained PSD-95 were pooled, concentrated in a Vivaspin concen-
trator (Vivascience, GE), reduced with DTT, alkylated with iodoace-
tamide and separated by one-dimensional SDS-electrophoresis 4–12%
(NUPAGE, Invitrogen, CA). The gel was fixed and stained with
colloidal Coomassie and entire gel lanes corresponding to the single-
step and tandem purifications from PSD-95TAP/TAP, and wt forebrains
were cut into slices and each slice was destained and digested
overnight with trypsin (Roche, Trypsinmodified, sequencing grade). A
solution digest was carried out on the same quantity of starting
material as the gel analyzed PSD-95TAPTAP and wt purifications.
Solution digests were carried out using sequencing grade, modified
trypsin (Promega) for 4.5 h at 371C.
LC-MS/MS analysis
Peptides extracted from gel slices were separated on a 40min RP
gradient and solution digests were separated on a 120-min gradient
using a PepMap C18 column (75-mm inner diameter 15 cm; LC
Packings). LC-MS/MS analysis was performed on an LTQ-FT (Thermo)
mass spectrometer in which the top five most intense ions in a given
chromatographic window were subjected to MS/MS sequencing. A
total of 102 LC-MS/MS analyses were performed and 59 885 MS/MS
spectra were acquired. All data were processed using BioWorks V3.2
(Thermo) and searched using Mascot V2.1 (Matrix science) against
mouse IPI sequence database (June, 2007). False discovery rates
determined by reverse database searches and empirical analyses of the
distributions of mass deviation and Mascot Ion Scores were used to
establish score and mass accuracy filters. Only proteins with two or
more approved unique peptides were accepted for gel-analysed
samples, whereas proteins with only one approved peptide found in
a solution digest experiment were required to be present in another
replicate analysis of the same solution digest with a different unique
peptide. Application of these filters to the PSD-95TAP/TAP datasets
resulted in ao1% false discovery rate as assessed by reverse database
searching. In general, proteins that were identified in both PSD-95TAP/TAP
and control experiments were not accepted. In cases, however, when a
protein was found specifically in the tandem TAP-PSD-95 purification
but not in the control tandem purification, but was present in both the
one-step TAP-PSD-95 purification and in the control single-step
purification, then the ratio of approved peptides in the one-step TAP-
PSD-95 purification/single-step control purification had to be 43 in
order for the protein to be accepted in the tandem purification. Protein
hits from all datasets were blast-clustered using a threshold of 95%
sequence homology over at least 50% of sequence length.
The data for this manuscript are open access according to the
Science Commons CC0 license and can be downloaded from the
Tranche network (http://tranche.proteomecommons.org) using the
following hash: (J9KSi8FHLDgHFyl2zz1LRq332aRrhVZl/cgPIJAO5W
G8tzhAhlrwxvHJOjnre8hIAKLFRTY11dRkXdIEtnkrlqUbg7gAAAAAA
AA8fw¼¼). In addition, the raw data are available in Peptide Atlas
(http://peptideatlas.org/repository). The protein interaction data have
been submitted to the IMEx consortium through the IntAct molecular
interaction database (http://www.ebi.ac.uk/intact) and assigned the
identifier IM-11694.
emPAI calculation
EmPAI values were calculated for each protein as described (Ishihama
et al, 2005) using the following formula: emPAI¼10PAI-1, where
PAI¼number of observed peptides/number of observable peptides.
The ratio of protein emPAI vales for proteins in the tandem
purification/single-step purification was calculated using emPAI
values that were normalized to the total protein emPAI in each
set and then normalized to the emPAI value of the bait protein
(PSD-95). The tandem-enriched set contained proteins specifically
identified in the tandem plus proteins identified in both tandem and
single-step purifications with an emPAI ratio (tandem/single step) of
40.5, 126 proteins, and the tandem-depleted set contained proteins
specifically identified in the single step plus proteins identified in
both tandem and single with an emPAI ratio (tandem/single step) of
o0.5, 175 proteins.
Network building and analysis
Proteins appearing in three or more of the replicate experiments
were used for the model. Out of these 118, five had gene ambiguity
(Cpne4, Tuba1a, Tubb2b, Uba52, and Vamp2) and were removed. A
final set of 113 proteins was used. Protein interaction data were
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sourced from the UniHi database (November 2008) (Chaurasia et al,
2007), with existing curated interactions in the NRC/MASC complex
described by Pocklington et al, 2006 and the additional interactions
obtained from literature. All interactions were manually re-curated.
Interactions sourced from UniHi were traced back to their original
database entries and the supporting reference was curated. No high-
throughput yeast 2 hybrid data were used unless confirmed by other
techniques.
Clustering was performed with the Newman & Girvan algorithm
(Newman andGirvan, 2004), using edge betweenness. Themodularity
coefficient (Q) for the clustering configuration used was 0.37. We
found clustering configurations with higher values (up to 0.42);
however, these configurations did not reflect the functional organiza-
tion of the network aswell as the one used.With the latter inmind, and
also on the basis of the observation that 0.37 was over the average of
examined configurations, we decided to use that. A shortest path is
defined as a path between two nodes such that the number of its
constituent edges is minimized. The average shortest path of a node
was calculated as the average of the shortest paths between the node
and all the other nodes in the network. Graphical representation of the
network was produced by Cytoscape.
Annotation overlap significance was performed according to
Pocklington et al (2006). The significance of the overlap between a
pair of annotations (e.g. ‘Glutamate Receptors’ and ‘Schizophrenia’)
was evaluated by calculating its probability of occurrence under a
randomdistribution. If within a set ofN proteins, na and nb possess the
annotations a and b, respectively, and both annotations are distributed
randomly in the set the probability of nab proteins possessing both
annotations is given by
hðnab; na; N; nbÞ ¼
na!ðN  naÞ!nb!ðN  nbÞ!
½N!ðna  nabÞ!nab!ðN  na  nb þ nabÞ!ðnb  nabÞ!
Given the actual number of proteins possessing the both annotations,
mab, we can estimate the significance by calculating the probability
P(mab) of an overlap as or less likely under the random distribution.
PðmabÞ ¼
X
nab
hðnab; na; N; nbÞ hðnab; na; N; nbÞphðmab; na; N; nbÞ
Additional methods
Detailed description of additional methods is available in the
Supplementary information. We described the electrophysiology
analysis, immunoprecipitation, immunoblotting, immunocytochem-
istry and immunohistochemistry. Primers used in this work are
summarized in Supplementary Table 7.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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